Skip to main content

Volume 10 Supplement 1

2nd Cross Company Respiratory Symposium

Meeting abstracts

Edited by Richard Knowles and Kathy H Abbott-Banner

The conference and publication of this supplement were supported by Pfizer. The organizing committee, which included a representative from Pfizer, was involved in selecting abstracts for oral and poster presentations at the meeting. RK is a scientific consultant on respiratory and inflammation models on drug discovery as well as CEO of an SME developing anti-inflammatory medicines. KAB has no competing interests.

2nd Cross Company Respiratory Symposium.

Horsham, UK6-7 September 2012

Concatenated PDF 10S1

Can't find what you're looking for?

Articles for this supplement are still being added to this new-look site. Please bear with us while we complete this work.

New Content Item

Affiliated with the British Inflammation Research Association (BIRAs).

Annual Journal Metrics

  • 2022 Citation Impact
    5.1 - 2-year Impact Factor
    5.1 - 5-year Impact Factor
    1.199 - SNIP (Source Normalized Impact per Paper)
    1.259 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    113 days submission to accept (Median)

    2023 Usage 
    462,203 downloads
    675 Altmetric mentions